PRESS-RELEASE ·Filed Sep 10, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed21d 20h ago WireGlobeNewswire
Press release: activist
Actionable Insight • Neutral

Routine executive hiring inducement with no immediate trading catalyst. Monitor for future pipeline updates or clinical data releases, which are the primary drivers for this pre-revenue biotech.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
SEPN ▲ +0.47% at T+5d
NEUTRAL call ✓ call won +0.47% · α vs SPY +0.69% · entry $38.51 → $38.69
Next anchor: T+20d in 6d
Latest observation: T+12 +7.10% FF3 residual α
Entry anchored
Sep 10, 04:00 PM ET
via 1-min bar
T+1d
+2.70%
call +2.70% · α +3.15%
$39.55
settled 21d ago
T+5d
+0.47%
call +0.47% · α +0.69%
$38.69
settled 15d ago
T+20d
—
call — · α —
—
in 6d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Septerna granted a 275,000-share non-qualified stock option inducement award to newly appointed CMO Rajiv Patni under the 2026 Inducement Plan, effective September 8, 2026. This is a routine hiring inducement for a biotech executive, not a material financial event. The filing has no revenue, earnings, or guidance data, and the stock option is standard for a new officer hire.

Key Facts

  • Septerna granted a non-qualified stock option to purchase 275,000 shares to new CMO Rajiv Patni
  • Grant effective September 8, 2026, under the 2026 Inducement Plan
  • Award is an inducement material to employment per Nasdaq Listing Rule 5635(c)(4)
  • No financial results, guidance, or material business developments disclosed

Financial Impact

275,000-share option grant; no dollar value stated

dilution

Risk Factors

  • Potential dilution from option exercise, though immaterial relative to outstanding shares
  • No revenue or near-term catalysts disclosed in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3359956
17 reports for SEPN
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +55.96%Apr 13, 2026
Filters
Rows
Reports for SEPN — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Press Release
NEUTRAL ★ 2/10
$38.51 $38.69▲ +0.47%▲ +0.69%$38.27 (−0.62%)
Sep 3, 2026
28d ago
3
NEUTRAL ★ 2/10
$36.75 $39.55▲ +7.62%▲ +8.83%$38.27 (+4.14%)
Aug 25, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$41.30 $37.68▼ −8.77%▼ −8.23%$38.27 (−7.34%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 7/10
$44.20 $40.52▲ +8.33%▲ +7.14%$38.27 (+13.42%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$44.20 $40.52▲ +8.33%▲ +7.14%$38.27 (+13.42%)
Aug 12, 2026
7w ago
144
BEARISH ★ 5/10
$45.14 $40.79▲ +9.64%▲ +7.67%$38.27 (+15.22%)
Aug 12, 2026
7w ago
144
BEARISH ★ 5/10
$45.14 $40.79▲ +9.64%▲ +7.67%$38.27 (+15.22%)
Aug 10, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$47.76 $43.80▼ −8.29%▼ −7.89%$38.27 (−19.87%)
Aug 10, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$47.76 $43.80▼ −8.29%▼ −7.89%$38.27 (−19.87%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.00 $37.84▲ +11.29%▲ +10.36%$38.27 (+12.56%)
Showing 10 of 17

US Market Status

Market Open — Closes in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 10, 2026